{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "http://kidneylifescience.ca/#organization",
      "name": "Institute of Kidney Lifescience Technologies",
      "url": "http://kidneylifescience.ca/",
      "description": "Institute of Kidney Lifescience Technologies Home Archived Resources About IKLT More than 1.9 million Canadians have Chronic Kidney Disease. We hope to reduce the burden of disease by early identification and prevention through education. RECORDINGS RESOURCES SGLT2 Inhibitors SGLT2 inhibition has been shown to provide cardioprotective and renal protective effects."
    },
    {
      "@type": "WebPage",
      "@id": "https://asg.websdocs.com/directory/business/institute-of-kidney-lifescience-technologies#asg",
      "name": "Institute of Kidney Lifescience Technologies ASG Directory Profile",
      "url": "https://asg.websdocs.com/directory/business/institute-of-kidney-lifescience-technologies",
      "isPartOf": {
        "@id": "http://kidneylifescience.ca/#organization"
      },
      "description": "Static AI-readable public business profile published by the WebsDocs ASG Directory."
    }
  ]
}